US strikes Syrian military targets

April 7, 2017

Washington, Apr 7: The U.S. military launched approximately 50 cruise missiles at a Syrian military airfield late on Thursday, in the first direct American assault on the government of President Bashar Assad since that country's civil war began six years ago.

usmissiles

The operation, which the Trump administration authorized in retaliation for a chemical attack killing scores of civilians this week, dramatically expands U.S. military involvement in Syria and exposes the United States to heightened risk of direct confrontation with Russia and Iran, both backing Assad in his attempt to crush his opposition.

The attack may put hundreds of American troops now stationed in Syria in greater danger. They are advising local forces in advance of a major assault on the Syrian city of Raqqa, the Islamic State's de facto capital.

The decision to strike follows 48 hours of intense deliberations by U.S. officials, and represents a significant break with the previous administration's reluctance to wade militarily into the Syrian civil war and shift any focus from the campaign against the Islamic State.

Senior White House officials met on the issue of Syria Wednesday evening in a session that lasted into early Thursday, and Defense Secretary Jim Mattis, Secretary of State Rex Tillerson and Army Lt. Gen. H.R. McMaster, the national security adviser, have communicated repeatedly since Tuesday's chemical attack, the officials said.

The U.S. Central Command has had plans for striking the Syrian government for years and currently has significant assets in the region, enabling a quick response once a decision was made.

While the Obama White House began operations against the Islamic State in 2014, it backed away from a planned assault on Syrian government sites a year earlier after a similar chemical attack on Syrian civilians.

Tuesday's apparent nerve gas attack in northern Idlib, with its widely circulated images of lifeless children, appears to have galvanized President Donald Trump and some of his top advisers to harden their position against the Syrian leader.

The assault adds new complexity to Syria's prolonged conflict, which includes fighters battling the Syrian government and others focused on combatting the Islamic State, which despite over two years of American and allied attacks remains a potent force.

Within the administration, some officials urged immediate action against Assad, warning against what one described as "paralysis through analysis." But others were concerned about second- and third-order effects, including the response of Russia, which also has installed sophisticated air-defense systems in Syria, according to the officials, who spoke on the condition of anonymity to discuss internal deliberations.

The Trump administration's position on the strongman appears to have quickly shifted in the wake of the chemical attack, as senior officials voiced new criticism of the Syrian leader.

Earlier Thursday, Tillerson suggested that the United States and other nations would consider somehow removing Assad from power, but he did not say how. Just a few days ago, the White House had said that removing Assad was not realistic with press secretary Sean Spicer saying it was necessary to accept the "political reality" in Syria.

"We are considering an appropriate response for this chemical weapons attack," Tillerson said in Palm Beach, Florida, where Trump was meeting Thursday with Chinese President Xi Jinping. "It is a serious matter. It requires a serious response," he said.

The summit with the Chinese leader will continue Friday, and some U.S. officials believe the strike will also serve as a warning of U.S. willingness to strike North Korea, if China does not act to curtail the nuclear ambitions of the government there.

It was not immediately clear whether Thursday's assault marked the beginning of a broader campaign against the Assad government. While Thursday's operation was the first intentional attack on Syrian government targets, the United States accidentally struck a group of Syrian soldiers in eastern Syria last year in what officials concluded was the result of human error.

The Obama administration had insisted that Assad could never remain in any postwar Syria, and it supported rebel groups that have tried unsuccessfully to oust him.

A senior State Department official said Tillerson spoke on the phone Wednesday with Russian Foreign Minister Sergei Lavrov about the chemical attack.

"We sought the Russian analysis or readout of what they thought had happened," the official said.

It is unclear if the U.S. provided any warning to Russia about the attack on Assad's military facilities.

The United States has a broad arsenal already in the region, including dozens of strike aircraft on the USS George H.W. Bush, an aircraft carrier that is deployed to the Middle East and accompanied by guided-missile destroyers and cruisers that can also launch Tomahawk cruise missiles.

Additionally, an amphibious naval force in the region includes the 24th Marine Expeditionary Unit with Harrier jets and Cobra gunships. The Pentagon also has scores of aircraft in the region flying operations every day against the Islamic State group, including from Incirlik air base to the north in Turkey.

It was not immediately clear if the attack only involved missiles or also included manned aircraft. U.S. fighter planes, if used, would have to contend with a modest web of Syrian air defenses and potentially more advanced types of surface-to-air missiles provided by Russia.

One of Assad's more prevalent systems, the S-200, was used to target Israeli jets last month, but missiles were intercepted by Israeli defense systems. The S-200 has a range of roughly 186 miles, according to U.S. military documents, and can hit targets flying at altitudes of around 130,000 feet.

Russian S-300 and S-400 missiles, located primarily around Khmeimim air base in western Syria, have a shorter range than the S-200, but have more-advanced radar systems and fly considerably faster than their older counterparts used by Syrian forces. The S-300 has a range of roughly 90 miles and could also be used to target incoming U.S. cruise missiles.

Sen. John McCain, R.-Ariz., chairman of the Senate Armed Services Committee, said in an interview Thursday that he and Trump have discussed Syria in the past few days, but he said the president did not talk in particular about military options.

McCain, who has long backed a more aggressive response to the Assad government, laid out a short list of goals for United States strikes.

"Take out his air assets. No airplane should fly. No more barrel bombs. No more sarin gas," the senator said.

McCain said he was glad to see Trump's position on striking Assad changing.

"I know that he was deeply moved, as we all were, at the spectacle of this slaughter," McCain said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 28,2020

More than one in six youths were jobless since the onset of the COVID-19 pandemic while those who remain employed have seen their working hours cut by 23 per cent, according to a report by the International Labour Organisation (ILO).

According to the 'ILO Monitor: COVID-19 and the world of work: 4th edition' published on Wednesday, youths are being disproportionately affected by the pandemic, and the substantial and rapid increase in youth unemployment seen since February is affecting young women more than young men, reports Xinhua news agency.

The pandemic is inflicting a triple shock on young people.

Not only is it destroying their employment, but it is also disrupting education and training, and placing major obstacles in the way of those seeking to enter the labour market or to move between jobs, said the report.

At 13.6 per cent, the youth unemployment rate in 2019 was already higher than any other group.

There were around 267 million young people not in employment, education or training worldwide.

"If we do not take significant and immediate action to improve their situation, the legacy of the virus could be with us for decades," said ILO Director-General Guy Ryder.

"If their talent and energy is sidelined by a lack of opportunity or skills, it will damage all our futures and make it much more difficult to re-build a better, post-COVID economy."

The report called for urgent, large-scale and targeted policy responses to support youth, including broad-based employment/training guarantee programs in developed countries, and employment-intensive programs and guarantees in low- and middle-income economies.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
April 5,2020

Washington, Apr 5: US President Donald Trump on Saturday said that he has requested Prime Minister Narendra Modi to supply Hydroxychloroquine tablets that can be used to treat COVID-19 patients.

"After call today with Indian Prime Minister Narendra Modi, India is giving serious consideration to releasing the hold it put on a US order for hydroxychloroquine," Trump announced at the White House Coronavirus task force briefing that he requested PM Narendra Modi for more Hydroxychloroquine tablets.

President Trump did not shy away from saying he too will take a tablet of hydroxychloroquine after announcing that he has requested Prime Minister during his telephonic conversation earlier today to lift a hold on the US order of the medicine.

"I may take it too, will have to talk to my doctors," he added.

"India makes a lot of it. They need a lot too for their billion-plus people. 

The hydroxychloroquine, the anti-malaria drug will be released through the Strategic National Stockpile for treatment," he said.

"I said I would appreciate if they would release the amounts that we ordered" of hydroxychloroquine, he said.

The Indian government has put on hold the export of anti-malarial drug hydroxychloroquine and its formulations.

Prime Minister Narendra Modi said on Twitter, "Had an extensive telephone conversation with President @realDonaldTrump. 

We had a good discussion, and agreed to deploy the full strength of the India-US partnership to fight COVID-19."

Prime Minister conveyed deep condolences for the loss of lives in the United States and his prayers for the early recovery of those still suffering from the disease.

As on Sunday, the United States has at least 301,902 cases of coronavirus according to Johns Hopkins University's tally. 

At least 8,175 people have died in the US from coronavirus.

There was a steep rise in the number of cases in the last 24 hours. At least 23,949 new cases were reported, and at least 1,023 new deaths in the US have been reported in the last 24 hours.

US Secretary of State Michael Pompeo had discussions with External Affairs Minister S Jaishankar about the importance of continued close cooperation between the United States and India to combat coronavirus by strengthening global pharmaceutical supply chains.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.